Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arsenault

Showing results (211-220 of 282) with videos related to

Pageof 29
Sort By:
HGG Advances|May 7, 2025
Aortic valve-specific genes dysregulated in calcific aortic valve stenosis as potential biomarkers and therapeutic targetsPardis Zamani, Ursula Houessou, Hasanga D Manikpurage, et al.
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Gastroenterology|February 3, 2023
Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute PancreatitisJérôme Bourgault, Erik Abner, Hasanga D Manikpurage, et al.
Atherosclerosis|June 23, 2017
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M Ballantyne, Ron C Hoogeveen, et al.
Heart (British Cardiac Society)|October 1, 2021
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosisYannick Kaiser, Nick S Nurmohamed, Jeffrey Kroon, et al.
Communications Medicine|July 1, 2025
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesionsHasanga D Manikpurage, Jérôme Bourgault, Ursula Houessou, et al.
Reproductive Biology and Endocrinology : RB&E|January 15, 2022
Human plasma pregnancy-associated miRNAs and their temporal variation within the first trimester of pregnancyCécilia Légaré, Andrée-Anne Clément, Véronique Desgagné, et al.
Pathogens (Basel, Switzerland)|May 27, 2026
Growth Enhancement of <i>Salmonella</i> by Tungstate TreatmentRobin C Anderson, Delila D Dominguez, Megan R Shaw, et al.
Journal of the American College of Cardiology|May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control studyRoeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.
European Heart Journal|February 20, 2009
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and womenJamal S Rana, Benoit J Arsenault, Jean-Pierre Després, et al.
Pageof 29

Showing results (211-220 of 282) with videos related to

Sort By:
Pageof 29
HGG Advances|May 7, 2025
Aortic valve-specific genes dysregulated in calcific aortic valve stenosis as potential biomarkers and therapeutic targetsPardis Zamani, Ursula Houessou, Hasanga D Manikpurage, et al.
JAMA Cardiology|July 9, 2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE TrialRishi Puri, Steven E Nissen, Benoit J Arsenault, et al.
Gastroenterology|February 3, 2023
Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute PancreatitisJérôme Bourgault, Erik Abner, Hasanga D Manikpurage, et al.
Atherosclerosis|June 23, 2017
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M Ballantyne, Ron C Hoogeveen, et al.
Heart (British Cardiac Society)|October 1, 2021
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosisYannick Kaiser, Nick S Nurmohamed, Jeffrey Kroon, et al.
Communications Medicine|July 1, 2025
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesionsHasanga D Manikpurage, Jérôme Bourgault, Ursula Houessou, et al.
Reproductive Biology and Endocrinology : RB&E|January 15, 2022
Human plasma pregnancy-associated miRNAs and their temporal variation within the first trimester of pregnancyCécilia Légaré, Andrée-Anne Clément, Véronique Desgagné, et al.
Pathogens (Basel, Switzerland)|May 27, 2026
Growth Enhancement of <i>Salmonella</i> by Tungstate TreatmentRobin C Anderson, Delila D Dominguez, Megan R Shaw, et al.
Journal of the American College of Cardiology|May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control studyRoeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.
European Heart Journal|February 20, 2009
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and womenJamal S Rana, Benoit J Arsenault, Jean-Pierre Després, et al.
Pageof 29